Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
05/2007
05/09/2007EP1781644A1 Macrocyclic beta-secretase inhibitors
05/09/2007EP1126855B1 Use of fused pyrrolocarbazoles for preventing/treating damage to sensory hair cells and cochlear neurons
05/09/2007CN1960970A Pyrrolidine derivatives as CB1-receptor antagonists
05/09/2007CN1958590A Derivative of oxazole p-camptothecin ester, preparation method and application
05/09/2007CN1958589A 6 (aryloxy methyl) ¿C 2 aryl ¿C 6, 7 dihydro 4H - pyrido [5,1 c ] [1,4] oxaxine ¿C 4 - ketone derivative, and preparation method
05/09/2007CN1314688C Pyridinebenzoxazine analog quinolone derivative and its preparation method and uses
05/08/2007US7214690 For therapy of acne, male- pattern baldness, sexual dysfunction, impotence, wasting diseases, hirsutism, hypogonadism, prostatic hyperplasia, osteoporosis, cancer cachexia, and hormone-dependent cancers
05/08/2007US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
05/08/2007US7214673 For therapy of psychosis and bipolar disorder
05/08/2007US7214538 fluoro or chromoionophore based on the covalent linkage of a fluoro or chromophore to an aza-crown-3 calix[4]arene ionophore; facilitating the treatment of various diseases, such as manic-depressive illness
05/03/2007WO2007050721A2 Heterocyclic aspartyl protease inhibitors
05/03/2007WO2007049675A1 Polycyclic carbamoylpyridone derivative having inhibitory activity on hiv integrase
05/03/2007WO2007048732A1 Use of 5-aminopyrazoles for controlling phytopathogenic harmful fungi, novel 5-aminopyrazoles, process for their preparation and composition comprising them
05/03/2007WO2007018998A3 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators
05/03/2007WO2007009007A3 Methods of treatment using hydroquinone ansamycins
05/03/2007US20070099976 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one, used for treating cellular proliferative disorders, nonproliferative degenerative disorders and viral diseases or infections
05/03/2007US20070099941 N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
05/03/2007US20070099940 Pth agonists
05/03/2007US20070099904 Pharmaceutical composition for the treatment of cns and other disorders
05/03/2007US20070099898 2,4-benzodiazepine derivatives, used for treating cardiovascular diseases, cognitive and neurodegenerative diseases
05/03/2007US20070099897 Therapeutic compounds
05/03/2007US20070099894 e.g. 3-[(2,4-Difluorophenyl)amino]-2-{[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]carbonyl}-7-phenylthieno[2,3-b]pyridin-6(7H)-one; autoimmune, neurodegenerative disorders, antiinflammatory agent; p38 MAP kinase inhibitor
05/03/2007US20070099877 N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
05/03/2007US20070099848 Rapamycin carbohydrate derivatives
05/03/2007US20070099249 Compositions and liquid crystals
05/03/2007CA2626976A1 Heterocyclic aspartyl protease inhibitors
05/03/2007CA2626956A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
05/02/2007EP1778696A2 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors
05/02/2007EP1778677A1 Heterocyclic condensed compounds useful as antidiuretic agents
05/02/2007EP1592694B1 Active ingredient particles with clopidogrel or a pharmaceutically acceptable salt thereof
05/02/2007EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
05/02/2007CN1956722A Improved cytotoxic agents comprising new maytansinoids
05/02/2007CN1313470C Method for preparing N-methyl benzothiazole lifumeisu
05/01/2007CA2283587C Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with n- or c-linked imidazoles
05/01/2007CA2188267C Use of tetrahydropteridine derivatives as no-synthase inhibitors
04/2007
04/26/2007WO2007047207A2 5-lipoxygenase-activating protein (flap) inhibitors
04/26/2007WO2007046022A2 Inhibitors of phosphodiesterase type-iv
04/26/2007WO2007045876A1 Chromenones and their use as modulators of metabotropic glutamate receptors
04/26/2007WO2007045622A1 Oxazolo [4 , 5-b] pyridine compounds as nitric oxide synthase inhibitors
04/26/2007WO2007029082A3 An improved fermentation process for preparing ascomycin
04/26/2007WO2007025307A3 Inhibitors of serine proteases
04/26/2007WO2007023382A3 Pyrimidine amino pyrazole compounds, potent kinase inhibitors
04/26/2007US20070093658 used for the treatment of a cancer in mammals; anticarnogenic or antitumor agents
04/26/2007US20070093521 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
04/26/2007US20070093509 Non-basic melanin concentrating hormone receptor-1 antagonists
04/26/2007US20070093508 Non-basic melanin concentrating hormone receptor-1 antagonists
04/26/2007US20070093498 Thieno-pyrimidine compounds having fungicidal activity
04/26/2007US20070093492 Pyrrolidine derivatives
04/26/2007US20070093482 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors
04/26/2007US20070093391 Weed control
04/26/2007CA2620248A1 Chromenones and their use as modulators of metabotropic glutamate receptors
04/25/2007EP1776370A1 Cci-779 derivatives and methods of making same
04/25/2007EP1776368A1 Inhibitors of hcv replication
04/25/2007EP1209151B1 4-substituted piperidine derivatives
04/25/2007CN1951939A Novel pyrrole derivatives as pharmaceutical agents
04/25/2007CN1951390A Pharmaceutical compositions comprising colloidal silicon dioxide
04/25/2007CN1312154C Purine derivatives as kinase inhibitors
04/25/2007CN1312136C Triazole derivatives as tachykinin receptor antagonists
04/25/2007CN1312131C Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent
04/24/2007US7208490 Having useful antibacterial activity against a wide range of human and veterinary pathogens; for therapy of microbial infections in mammals
04/24/2007US7208488 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling
04/24/2007CA2197793C New multimerizing agents
04/24/2007CA2171934C Endothelin receptor antagonists
04/24/2007CA2166811C Tricyclic inhibitors of the gpiibiiia receptor
04/19/2007WO2007044978A1 Method of tacrolimus extraction and quantification using aqueous detergents
04/19/2007WO2007044933A1 Hepatitis c virus inhibitors
04/19/2007WO2007044885A2 Piperidine derivatives and methods of use
04/19/2007WO2007044804A2 Piperidine derivatives and methods of use
04/19/2007WO2007042325A1 Antibacterial active 5-chinolin derivative
04/19/2007WO2007000325A3 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-on- compounds and the use thereof for producing drugs
04/19/2007WO2006101217A3 Luminous compound containing lanthanide ion
04/19/2007US20070088159 Hydroxyalkyl cyclic diamine compounds
04/19/2007US20070088059 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
04/19/2007US20070088049 Polymorphic forms of methyl (+)-(s) - alpha - (2-chlorophenyl)-6, 7-dihydrothieno [3,2-c]pyridine-5(4h) acetate hydrobromide, clopidogrel hydrobromide
04/19/2007US20070088048 Clopidogrel salt and polymorphic forms thereof
04/19/2007US20070088036 1-[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carbonitrile; -[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carboxylic acid methyl ester; deposited on a stent or stent-graft device
04/19/2007US20070088025 Tricyclic 1-[(indol-3-yl)carbonyl]piperazine derivatives as cannabinoid cb1 receptor agonists
04/19/2007CA2625687A1 Antibacterial active 5-chinolin derivative
04/19/2007CA2625649A1 Method of tacrolimus extraction and quantification using aqueous detergents
04/18/2007EP1773844A1 Compounds having affinity for the dopamine d3 receptor and uses thereof in medicine
04/18/2007EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
04/18/2007EP1773346A1 Substituted quinobenzoxazine analogs and methods of using thereof
04/18/2007EP1773343A1 Antibacterial agents
04/18/2007EP1553949B1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
04/18/2007EP1455792B1 Ureas of 2-aminobenzothiazoles as adenosine modulators
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/18/2007CN1950380A (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
04/18/2007CN1950378A Thienopyridazines as ikk inhibitors
04/18/2007CN1950377A Thienopyridines as IKK inhibitors
04/18/2007CN1948315A Tricycle compounds and its application in making medicine
04/18/2007CN1310922C Fused bicyclic pyridine derivative as tachykinin receptor antagonist
04/18/2007CN1310919C 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
04/17/2007USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators
04/17/2007US7205408 Therapy for bacteria infections in mammals
04/17/2007US7205334 vacuolar-type (H+)-ATPase-inhibiting macrocyclic lactams belonging to the chondropsin class useful in cancer chemotherapy
04/17/2007US7205300 Aryl fused azapolycyclic compounds
04/17/2007US7205295 such as 4-(4-tert-Butyl-benzyl)-6-(4-oxo-2-thioxo-thiazolidin-5-ylidenemethyl)-4H-1,4-benzoxazin-3-one; phosphoinositide-3-kinases (PI3Ks); for treatment/prevention of inflammatory diseases, cardiovascular diseases, and cancers
04/17/2007CA2350073C Ccr5 modulators
04/17/2007CA2124260C Tetrahydropyran derivatives
04/12/2007WO2007041052A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 220